Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines for blood pressure coexist, emanating from European,1,2 North American,3 ...

Discover how a single daily pill is transforming hypertension treatment. Simplified care and better results are reshaping ...

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...

Hypertension in pregnancy increases the likelihood of postpartum hypertension. Know the risk factors to start managing ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to ...

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...